Brief: Paion Announces Clinical Development Progress With Remimazolam By Its Partner R-Pharm In Russia

PAION AG

17/05/2018 13:07

May 17 (Reuters) - Paion AG  PA8G.DE :
    * 
    * ANNOUNCES CLINICAL DEVELOPMENT PROGRESS WITH REMIMAZOLAM
BY ITS
PARTNER R-PHARM IN RUSSIA
    * R-PHARM SUCCESSFULLY COMPLETES PATIENT RECRUITMENT OF A
PHASE
III TRIAL IN GENERAL ANESTHESIA

Source text for Eikon:  ID:nEQ6Jr8fta 
Further company coverage:  PA8G.DE 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))